Divi’s Laboratories

Divi’s Laboratories is a premier global pharmaceutical company and one of the world’s largest manufacturers of Active Pharmaceutical Ingredients (APIs), intermediates, and nutraceutical ingredients. Established in 1990, the company has grown exponentially to become a trusted partner for top global pharmaceutical companies. Headquartered in Hyderabad, India, Divi’s operates world-class manufacturing facilities that comply with the most stringent global regulatory standards, including approvals from the US FDA, EU GMP, and PMDA.

The company’s core expertise lies in developing highly efficient, sustainable, and scalable chemical processes for complex molecules. Divi’s has a massive production capacity, operating thousands of reactors across its vast manufacturing sites, which ensures a reliable and uninterrupted supply chain for critical medications globally.

The organization places a heavy emphasis on research and development, employing hundreds of specialized scientists in its state-of-the-art R&D centers. These teams focus on custom synthesis, advanced intermediates, and non-infringing processes for generic APIs, ensuring cost-effectiveness and high quality. Divi’s is particularly renowned for its capabilities in continuous flow chemistry, photochemistry, and chiral synthesis.

In addition to its API dominance, Divi’s is a global leader in the synthesis of carotenoids and vitamins, supplying the food, feed, and dietary supplement industries. Committed to environmental, social, and governance (ESG) principles, the company continuously invests in green chemistry and advanced wastewater treatment facilities to minimize its ecological footprint. Through strategic partnerships, continuous innovation, and an unwavering commitment to quality, Divi’s Laboratories remains at the forefront of the global pharmaceutical supply chain, playing a pivotal role in bringing life-saving medicines to millions of patients worldwide.